Business News

Sun Pharma signs agreement to acquire 85% stake in Russian firm Biosintez for $24 million

As part of the deal, the drug major will also assume a debt of around $36 million from the company.

Indian drug firm Sun Pharma will acquire an 85.1% stake in Russian company JSC Biosintez for $24 million (Rs 160 crore approximately). The company issued a statement on Wednesday saying that it has signed the definitive agreements for the acquisition.

As part of this agreement, the drug major will also assume a debt of around $36 million (Rs 239 crore approximately) from the Russian firm. The entire transaction, worth $60 million (Rs 400 crore approximately), is likely to be completed by the end of this year. However, it needs to be approved by the Russian Federal Anti-Monopoly Service, reported IANS.

“This acquisition is consistent with Sun Pharma’s philosophy to invest in strategic emerging markets. This transaction gives us access to local manufacturing capability across multiple dosage forms in Russia, enabling us to serve the Russia pharmaceutical market more effectively,” said Aalok Shanghvi, Head of Emerging Markets at Sun Pharma.

JSC Biosintez is a Russian pharmaceutical major that manufactures and markets pharmaceutical products with its primary focus on the hospital segment. Apart from medicines, tablets and ointment, the firm manufactures pharmaceuticals for injections, blood substitutes, blood preservatives also. It has a manufacturing facility in Penza region. In 2015, the company’s annual revenue was $52 million (Rs 346 crore approximately).

Russia is one of the many countries where Sun Pharma is interested in growing its business. Ranjit Kapadia, senior Vice President at Centrum Broking, told Mint that this is a “small” acquisition for a firm like Sun Pharma. “This [acquisition] will increase the company’s presence in Russia and help in meeting future regulatory requirements in that market.” Kapradia, however, warned that “sharp currency fluctuations” make Russia a challenging market.

Support our journalism by subscribing to Scroll+ here. We welcome your comments at letters@scroll.in.
Sponsored Content BY 

Following a mountaineer as he reaches the summit of Mount Everest

Accounts from Vikas Dimri’s second attempt reveal the immense fortitude and strength needed to summit the Everest.

Vikas Dimri made a huge attempt last year to climb the Mount Everest. Fate had other plans. Thwarted by unfavourable weather at the last minute, he came so close and yet not close enough to say he was at the top. But that did not deter him. Vikas is back on the Everest trail now, and this time he’s sharing his experiences at every leg of the journey.

The Everest journey began from the Lukla airport, known for its dicey landing conditions. It reminded him of the failed expedition, but he still moved on to Namche Bazaar - the staging point for Everest expeditions - with a positive mind. Vikas let the wisdom of the mountains guide him as he battled doubt and memories of the previous expedition. In his words, the Everest taught him that, “To conquer our personal Everest, we need to drop all our unnecessary baggage, be it physical or mental or even emotional”.

Vikas used a ‘descent for ascent’ approach to acclimatise. In this approach, mountaineers gain altitude during the day, but descend to catch some sleep. Acclimatising to such high altitudes is crucial as the lack of adequate oxygen can cause dizziness, nausea, headache and even muscle death. As Vikas prepared to scale the riskiest part of the climb - the unstable and continuously melting Khumbhu ice fall - he pondered over his journey so far.

His brother’s diagnosis of a heart condition in his youth was a wakeup call for the rather sedentary Vikas, and that is when he started focusing on his health more. For the first time in his life, he began to appreciate the power of nutrition and experimented with different diets and supplements for their health benefits. His quest for better health also motivated him to take up hiking, marathon running, squash and, eventually, a summit of the Everest.

Back in the Himalayas, after a string of sleepless nights, Vikas and his team ascended to Camp 2 (6,500m) as planned, and then descended to Base Camp for the basic luxuries - hot shower, hot lunch and essential supplements. Back up at Camp 2, the weather played spoiler again as a jet stream - a fast-flowing, narrow air current - moved right over the mountain. Wisdom from the mountains helped Vikas maintain perspective as they were required to descend 15km to Pheriche Valley. He accepted that “strength lies not merely in chasing the big dream, but also in...accepting that things could go wrong.”

At Camp 4 (8,000m), famously known as the death zone, Vikas caught a clear glimpse of the summit – his dream standing rather tall in front of him.

It was the 18th of May 2018 and Vikas finally reached the top. The top of his Everest…the top of Mount Everest!

Watch the video below to see actual moments from Vikas’ climb.

Play

Vikas credits his strength to dedication, exercise and a healthy diet. He credits dietary supplements for helping him sustain himself in the inhuman conditions on Mount Everest. On heights like these where the oxygen supply drops to 1/3rd the levels on the ground, the body requires 3 times the regular blood volume to pump the requisite amount of oxygen. He, thus, doesn’t embark on an expedition without double checking his supplements and uses Livogen as an aid to maintain adequate amounts of iron in his blood.

Livogen is proud to have supported Vikas Dimri on his ambitious quest and salutes his spirit. To read more about the benefits of iron, see here. To read Vikas Dimri’s account of his expedition, click here.

This article was produced by the Scroll marketing team on behalf of Livogen and not by the Scroll editorial team.